An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

Steven Huy B. Han, Joshua Ofman, Curtis Holt, Kevin King, Gregg Kunder, Pauline Chen, Sherfield Dawson, Leonard Goldstein, Hasan Yersiz, Douglas G. Farmer, Rafik M. Ghobrial, Ronald W. Busuttil, Paul Martin

Research output: Contribution to journalArticlepeer-review

218 Scopus citations

Fingerprint

Dive into the research topics of 'An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences